If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPatria Private Regulatory News (PPET)

Share Price Information for Patria Private (PPET)

Share Price is delayed by 15 minutes
Get Live Data
618.00    0.00 (0.00%)
Bid:
616.00
Ask:
622.00
Spread: 6.00 (0.974%)
Market Cap: £903.86m
PPET Live PriceLast checked at - London Stock Exchange

Intraday Patria Private Share Chart

Portfolio Disposal

23 Oct 2024 07:00

RNS Number : 1956J
Patria Private Equity Trust PLC
23 October 2024
 

 

23 October 2024

 

Patria Private Equity Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

£180 million Portfolio Disposal

 

Patria Private Equity Trust plc ("PPET" or "the Company") is pleased to announce that it has completed the sale of a portfolio of 14 underlying fund investments (the "Divested Funds") for approximately £180 million (the "Transaction").

 

The disposal realises a combined overall return of 1.9x Multiple on Invested Capital and 16% IRR for the Divested Funds.

 

The Transaction

 

The Divested Funds comprise 14 fund investments, representing 13% of the Company's portfolio at 31 August 2024. All of the Divested Funds were older vintage investments or had become less aligned with PPET's strategy, given the Company's increased focus on the European mid-market buyout space.

 

Key elements of the Transaction are as follows:

 

· The Divested Funds were sold for €216 million (£180 million) representing 95% of valuation at 31 March 2024 (the Transaction reference date).

 

· Consideration from the Transaction will be received in two tranches - the first contractual payment is due in December 2024 (approximately 45% of the disposal proceeds) and the second contractual payment is due in September 2025 (the remaining 55% of the disposal proceeds).

 

· The Transaction results from a competitive sales process run by an established secondary intermediary with a number of high-quality secondary players participating and has delivered a strong outcome for PPET.

 

· Ten of the 14 Divested Funds, representing 50% of the transaction value, were from older vintage years between 2011 and 2016. The remaining four Divested Funds were from vintages between 2017 and 2019, but were weighted to the large-cap buyout space and deemed to have become non-core to PPET's strategy, given its increased focus on the European mid-market buyout space.

 

Use of Proceeds

 

The £180m million disposal proceeds provide PPET with the opportunity to:

 

· Reduce drawings on the Company's revolving credit facility and increase balance sheet strength. As at 31 August 2024, the £300 million facility was £142.3 million drawn. Including the deferred proceeds, the Company will have short term resources of £333 million available. Outstanding commitments were £634.1 million as at 31 August 2024, of which £93.3 million are not expected to be drawn.

 

· Provide additional firepower for new accretive investments and corporate initiatives.

 

· Continue to focus the portfolio towards the mid-market buyout space, including increasing the Company's allocation to direct investments (currently representing 23% of the portfolio at 31 August 2024).

 

Alan Devine, Chair of Patria Private Equity Trust plc, commented:

 

"This Transaction further underlines the quality and attractiveness of our broader portfolio. The price achieved by our Manager demonstrates PPET's ability to extract value even from non-core assets and unlock capital for future growth initiatives. The Board is particularly pleased to have achieved this outcome given the share price discount to NAV."

 

Alan Gauld, PPET's Lead Investment Manager, commented:

 

"As manager of PPET, we are continually monitoring both buy-side and sell-side opportunities in the secondary market. The investments we are selling in this transaction have performed well, but many were from older vintage years or focused outside of the mid-market buyout space. We were very pleased with the quality of buyer interest and the pricing achieved further illustrates the disconnect between the valuations of listed private equity investment trusts relative to the quality and attractions of their underlying portfolios."

 

 

For further information please contact:

 

Patria Private Equity Trust plc

PPET.Board@patria.com

Alan Devine (Chair)

 

Alan Gauld (Lead Manager)

Paul Evitt (Company Secretary)

 

 

 

Investec Bank plc

+44 (0)20 7597 4000

Lucy Lewis

 

Tom Skinner

 

Denis Flanagan

 

 

SEC Newgate

+44 (0)20 3757 6872

Sally Walton

 

 

Notes:

 

Patria Private Equity Trust plc (Ticker: PPET) is an investment trust with a premium listing on the London Stock Exchange.

 

PPET provides investors with exposure to leading private equity funds and private companies, mainly in Europe. It invests in private equity funds by making primary commitments and secondary purchases, and it makes direct investments into private companies. Its investment objective is to achieve long-term total returns for investors and its policy is to maintain a broadly diversified portfolio by country, industry sector, maturity and number of underlying investments.

 

Patria Capital Partners LLP, a wholly owned subsidiary of Patria Investments Limited, is PPET's alternative investment fund manager ('AIFM') and Manager (the 'Investment Manager' or the 'Manager').

 

Further information on the Company can be found on its website at: https://patriaprivateequitytrust.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISPPGGCUUPCGQP
Date   Source Headline
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSNet Asset Value(s)
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20262:44 pmRNSHolding(s) in Company
2nd Mar 202611:44 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20269:41 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 202612:39 pmRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20264:15 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSEstimated NAV at 31 December 2025
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 202610:38 amRNSDirector/PDMR Shareholding
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:03 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSAnnual Financial Report
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20264:38 pmRNSQuarterly Disclosure
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSNotice of Results
6th Jan 20267:00 amRNSEstimated NAV at 30 November 2025
29th Dec 20259:54 amRNS-REdison issues report on Patria Private Equity Trust (PPET)
1st Dec 20251:40 pmRNSDividend Declaration
1st Dec 20257:00 amRNSEstimated NAV at 31 October 2025
4th Nov 202510:23 amRNSEstimated NAV at 30 September 2025 - Amendment
4th Nov 20257:00 amRNSEstimated NAV at 30 September 2025
3rd Nov 20253:00 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:36 amRNSTotal Voting Rights
31st Oct 20252:53 pmRNS-RUpdate from QuotedData
9th Oct 20258:45 amRNSQuarterly Disclosure
9th Oct 20257:00 amRNSBoard Succession Planning
6th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSEstimated NAV at 31 August 2025
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.